What's Actually Going On
A pulmonary embolism is usually the second act of a clot in a leg vein. The clot forms in a leg whose calf-muscle pump has stopped working, breaks free, travels through the right side of the heart, and lodges in the arteries of the lungs.
Every circumstance that made that leg a clot risk is a musculoskeletal one: a cast, a walking boot, a non-weightbearing instruction, surgery, an injury, a long flight, a stretch of sitting still. The pathway that produces a clot on the lung runs straight through this profession's caseload, which is why recognising it belongs here even though treating it never does.
The physiology explains why the same condition produces two presentations that look nothing alike. A clot in a small vessel at the edge of the lung kills off a wedge of tissue pressed against the chest lining, and that lining is dense with pain nerves, so it produces sharp, breathing-linked, often positionally reproducible pain. A clot in a large central vessel produces no pleural contact at all, and instead abruptly loads the right side of the heart, producing breathlessness, light-headedness or collapse with little or no pain. The useful consequence: the more mechanical it sounds, the more likely it is to be missed, and the less chest pain there is, the sicker the person may be.
How to Identify It
This is the part of the card that differs most from every other condition in this library, and the difference is the finding. The accuracy data here is abundant and high quality. None of it belongs to a physical therapist.
That last row is not a gap in this search. Across 184 papers and nine search strategies, not one study reported the accuracy of any individual bedside sign for a clot on the lung. Every validated instrument in this literature is either a multi-item scoring rule or an imaging test. There is no hands-on finding that clears someone, and a negative bedside test must not contribute to a decision to keep treating.
What the clinician actually holds is the history. The discriminating question is not what the pain feels like, it is what happened in the weeks before it started: immobilisation, surgery, injury, travel, prolonged sitting, previous clots, hormonal contraception, pregnancy, cancer. Ask directly about fainting, because people volunteer chest pain and conceal near-fainting.
The differentials that matter, and how each one behaves:
The Debate
Does a validated rule stay valid when you move it?
Standard practice, per the governing guideline (ESC 2019)
Assign a clinical probability, apply the matching D-dimer threshold, image anything that is not excluded. Each rule carries a published miss rate, and those miss rates are quoted as properties of the rule.
VS
Geersing 2022, individual patient data from 23 studies, ~35,000 patients
Tested separately in four settings, the PERC rule excluded clots at a miss rate of 1.12% in walk-in emergency care and 6.01% in patients referred to secondary care. Same rule, same criteria, fivefold difference.
Follow the newer evidence. A rule's published safety belongs to the setting that produced it. Prevalence in tested emergency department groups runs 23% in Europe against 8% in North America (Germini 2021), so the denominator the rule was tuned to is not a fixed fact. A musculoskeletal clinic was not one of the four settings anyone has measured, which is why this page teaches escalation and refuses to teach a rule-out.
The rest of the diagnostic framework is genuinely settled, and worth saying so plainly. Refinements have continued (a 4-level probability score derived and externally validated, and a randomised trial combining two algorithms), but no recent evidence has displaced the basic pathway. What is moving is rehabilitation after the event, which is precisely where physical therapy sits.
Honest Limitations
Every diagnostic study here was done somewhere a physical therapist does not work
What the research shows: validated rules achieve miss rates near or below 2% when correctly applied.
The gap: the settings measured were walk-in emergency care, primary care clinics, referred secondary care, and hospital or nursing home. Musculoskeletal outpatient clinics, private practice and sports settings appear in this literature only as individual case reports. The rules were never calibrated to this room, and this room has never been counted.
What to do about it: do not stratify. Escalate on a risk factor plus an unexplained breathing or circulation symptom, and let someone who can order the scan run the pathway.
The evidence closest to this caseload is the weakest by design
What the research shows: among 47 published cases in trained people, 53.2% were misdiagnosed first, with an average of 56 days from first symptom to diagnosis.
The gap: published case reports are selected for being interesting, which biases toward the delayed and the misdiagnosed. That figure describes cases that reached print, not a rate in the population.
What to do about it: trust the direction, hold the exact number loosely. Two much stronger studies point the same way, one finding this the most reported missed diagnosis among 583 physician-reported errors, the other finding a third of confirmed cases diagnosed late.
The rehabilitation trials recruited a fraction of the people who have this
What the research shows: exercise after a clot is safe, with 87% adherence.
The gap: one trial screened 239 people after an acute clot, found 43 eligible, and randomised 19. Adherence inside a trial describes people who agreed to be in a trial.
What to do about it: trust the safety signal, which is consistent everywhere. Expect a less selected and less adherent real caseload than the effectiveness numbers imply.
The Nuance
The simple version of this page says escalate whenever you are unsure. The nuance is that over-calling is not free, and the evidence for that is uncomfortable to read. Guidelines recommend starting blood thinners on a high clinical suspicion before the workup completes. Three published cases show what that costs when the suspicion is confidently wrong: a 35-year-old woman who died of a ruptured aortic aneurysm, a man who died of a brain haemorrhage, and a woman with life-threatening bleeding into the chest after minor trauma. None of them had a clot (van den Oever 2015).
That is why the recommended action is precisely worded. It is not "diagnose a clot" and it is not "reassure". It is escalate for assessment, describe your findings plainly, and offer neither a diagnosis you cannot confirm nor reassurance you cannot support. Both errors have a named mechanism of harm and only one action avoids both.
The best illustration in the whole corpus runs in this profession's favour. A physical therapist assessed a 39-year-old non-smoking man with rheumatoid arthritis and four weeks of calf pain that started at the gym, concluded it was a clot rather than the calf strain the patient believed he had, and sent him on with a written referral letter. The minor injuries unit reversed it back to a calf strain. He sought a third opinion, and an ultrasound confirmed the clot (Lewis 2020). The assessment was right, and the documentation is what survived being overruled. His youth, his fitness and the fact that it started during exercise argued the wrong way at every single step.
One more piece of nuance for the treatment side. Where a clot sits on the medical risk scale determines almost everything about the care that follows: in-hospital death runs 20.3% in high-risk patients, 4.0% in intermediate-risk and 0.5% in low-risk (Becattini 2023, 5,213 patients). None of that is a physical therapy decision. The honest summary is that this profession's contribution to the outcome is concentrated almost entirely in the hours before the diagnosis and the weeks after treatment starts, and in between the job is to stay out of the way.
